Opdivo and Yervoy improve cure rates in resected stage 3/4 melanoma compared to placebo, with Opdivo showing superior efficacy. CheckMate 238 and EORTC 18071 trials reveal Opdivo's cure rate advantage ...

A British woman diagnosed with stage 4 skin cancer has asked young people not to make the same mistakes she made in her ...